4.7 Review

Neurosteroid regulation of central nervous system development

Journal

PHARMACOLOGY & THERAPEUTICS
Volume 116, Issue 1, Pages 107-124

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2007.04.011

Keywords

pregnenolone; progesterone; allopregnanolone; dehydroepiandrosterone; Neurogenesis; neurotoxicity; neurodegeneration; Niemann pick type C

Funding

  1. NINDS NIH HHS [U01 NS049462-02, U01 NS049462-01A1, U01 NS049462-03, U01 NS049462] Funding Source: Medline

Ask authors/readers for more resources

Neurosteroids are a relatively new class of neuroactive compounds brought to prominence in the past 2 decades. Despite knowing of their presence in the nervous system of various species for over 20 years and knowing of their functions as GABA(A) and N-methyl-D-aspartate (NMDA) ligands, new and unexpected functions of these compounds are continuously being identified. Absence or reduced concentrations of neurosteroids during development and in adults may be associated with neurodevelopmental, psychiatric, or behavioral disorders. Treatment with physiologic or pharmacologic concentrations of these compounds may also promote neurogenesis, neuronal survival, myelination, increased memory, and reduced neurotoxicity. This review highlights what is currently known about the neurodevelopmental functions and mechanisms of action of 4 distinct neurosteroids: pregnenolone, progesterone, allopregnanolone, and dehydroepiandrosterone (DHEA). (c) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available